This review discusses how inherited variation in cytokine-regulatory pathways may influence IL-6, TNF-α, interferon, and TGF-β signaling, thereby contributing to inflammatory set points that favor chronic immune activation and inflammaging.
This review synthesizes emerging molecular and epigenetic frameworks that redefine immunosenescence as a quantifiable and disease-modifiable dimension of biological aging rather than a passive consequence of chronological time, and highlights actionable biomarkers that enable precise stratification of immune biological...
Overall, immune senescence should be recognized as a fundamental component of autoimmune rheumatic diseases, providing important opportunities for improving diagnosis, risk stratification, therapeutic decision-making, and long-term clinical outcomes in aging populations.
It is proposed that T1D may induce a state of premature immunosenescence, even in relatively young individuals, which may further exacerbate autoimmunity, creating a self-reinforcing cycle between autoimmunity and immune aging mechanisms.
D. Saavedra, Rahul Mittal, C. Blaschke et al.· Diabetes· 0 citations
A comprehensive understanding of the mechanisms by which endocrino-immuno-senescence is coordinately associated with a variety of pathological processes is provided and new insights into immunomodulatory strategies ameliorating age-related diseases for healthy aging and quality living are delineated.
P. Manna, Shengping Yang, Chayan Manna et al.· Aging and Disease· 0 citations
This framework provides a testable model and supports interventional studies to determine whether restoration of SCFA signaling-such as through early administration of butyrate-producing microbes or tributyrin (a stable butyrate triglyceride)-can favorably alter immune trajectories and improve clinical outcomes.
Yu-Yeung Yip, Kwok M. Ho· Journal of critical care· 0 citations
A deeper understanding of how aging-related immune dysfunction interacts with prostate cancer biology may help improve patient stratification and support the development of more individualized treatment strategies for older prostate cancer patients.
Juntao Guo, Ke Wu, Zheng Ma et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.